Literature DB >> 1235298

Susceptibility to primary irritants: age dependence and relation to contact allergic reactions.

P J Coenraads, E Bleumink, J P Nater.   

Abstract

Patch tests with three primary irritants were performed in 600 persons with eczema and in 33 healthy controls, The irritants assayed were: croton oil (20%) in mineral oil, thymoquinone (1%) in ethanol and crotonaldehyde (7.5%) plus sodium lauryl sulphate (4%) in aqua dest. The number of positive reactions to croton oil was found to decrease with age, while for thymoquinone and crotonaldehyde and for the total irritant score no age dependence was observed. No significant correlation was found between sensitization to common contact allergens and susceptibility to irritants. The incidence of positive reactions to common allergens proved to increase with age.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1235298     DOI: 10.1111/j.1600-0536.1975.tb05478.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  4 in total

1.  Crotonaldehyde exposure in U.S. tobacco smokers and nonsmokers: NHANES 2005-2006 and 2011-2012.

Authors:  Pritha Bagchi; Nathan Geldner; B Rey deCastro; Víctor R De Jesús; Sang Ki Park; Benjamin C Blount
Journal:  Environ Res       Date:  2018-02-03       Impact factor: 6.498

Review 2.  Diagnosis and treatment of allergic skin disorders in the elderly.

Authors:  S T Nedorost; S R Stevens
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Nationwide Survey and Identification of Potential Stress Factor in Sensitive Skin of Chinese Women.

Authors:  Xiaoqing Xiao; Liyuan Qiao; Rui Ye; Fuguo Zuo
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-11-20

Review 4.  Thymoquinone in Ocular Neurodegeneration: Modulation of Pathological Mechanisms via Multiple Pathways.

Authors:  Nur Musfirah Mahmud; Luminita Paraoan; Nurliza Khaliddin; Tengku Ain Kamalden
Journal:  Front Cell Neurosci       Date:  2022-03-02       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.